BB3

DRUG3 trials

Sponsors

Angion Biomedica Corp

Conditions

Delayed Graft FunctionMyocardial Infarction

Phase 2

Study to Improve Renal Function After Kidney Transplantation

Angion Biomedica CorpDelayed Graft Function

Start: 2010-02-28End: 2016-02-29Target: 30Updated: 2015-05-05

Study to Evaluate the Safety and Activity of BB3 to Treat Heart Attack

TerminatedNCT01539590

Angion Biomedica CorpMyocardial Infarction

Start: 2012-07-31End: 2013-11-30Updated: 2014-11-21

Study on Delayed Graft Function Using Paired Kidneys

Angion Biomedica CorpDelayed Graft Function

Start: 2011-08-31End: 2016-05-31Updated: 2016-02-22